Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1997 Jan;50(1):16–21. doi: 10.1136/jcp.50.1.16

The value of immunohistochemistry on paraffin wax embedded tissue sections in the differentiation of small lymphocytic and mantle cell lymphomas.

N Singh 1, D H Wright 1
PMCID: PMC499705  PMID: 9059349

Abstract

AIMS: To determine whether immunohistochemistry applied to paraffin wax embedded biopsy tissue can be used to distinguish between B-small lymphocytic lymphoma (B-SLL) and mantle cell lymphoma (MCL). METHODS: Formalin fixed, paraffin wax embedded tissue blocks of 12 cases of B-SLL and 12 cases of MCL were retrieved from the files of the Department of Pathology, Southampton University Hospitals Trust. Following antigen retrieval, where appropriate, sections were stained for CD3, CD5, CD20, CD23, CD43, Cyclin D, PGP9.5, and MIB1 using a streptavidin-biotin complex technique. RESULTS: CD20 stained the neoplastic cells of B-SLL and MCL, and CD3 labelled the reactive T cells in these tumours. In B-SLL, the T cells were generally dispersed among the tumour cells, whereas in MCL they often formed bands around tumour cell nodules. CD5 could be detected on T cells, following antigen retrieval. The level of expression on B cells of B-SLL and MCL was generally too low to allow detection in paraffin wax embedded tissues. CD23 stained B-SLL but not MCL. However, it could be detected in only five of the 12 cases of B-SLL. CD43 could be detected in most cases of B-SLL and MCL. It is not, therefore, of value in distinguishing between these tumours. It will, however, help in the differentiation of B-SLL and MCL from other low grade B cell lymphomas, such as follicle centre cell and marginal zone lymphomas. Cyclin D was expressed in all of the MCL but in none of the B-SLL. PGP9.5 showed reactivity in most cases of MCL and much weaker reactivity in B-SLL. The proliferation indexes of MCL were generally higher than those of B-SLL, as measured by MIB1 labelling. Both tumours, however, showed a wide range of values and considerable overlap. CONCLUSION: Staining for Cyclin D is the most reliable immunohistochemical mean of differentiating between B-SLL an MCL. High levels of PGP9.5, expressed in MCL, may be related to the degradation of Cyclin D by the ubiquitin pathway.

Full text

PDF
16

Images in this article

17Image
on p.17
17Image
on p.17
18Image
on p.18
18Image
on p.18
18Image
on p.18
18Image
on p.18
18Image
on p.18
19Image
on p.19
19Image
on p.19
19Image
on p.19
19Image
on p.19
19Image
on p.19
19Image
on p.19
20Image
on p.20
20Image
on p.20

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banks P. M., Chan J., Cleary M. L., Delsol G., De Wolf-Peeters C., Gatter K., Grogan T. M., Harris N. L., Isaacson P. G., Jaffe E. S. Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol. 1992 Jul;16(7):637–640. doi: 10.1097/00000478-199207000-00001. [DOI] [PubMed] [Google Scholar]
  2. Berger F., Felman P., Sonet A., Salles G., Bastion Y., Bryon P. A., Coiffier B. Nonfollicular small B-cell lymphomas: a heterogeneous group of patients with distinct clinical features and outcome. Blood. 1994 May 15;83(10):2829–2835. [PubMed] [Google Scholar]
  3. Cuevas E. C., Bateman A. C., Wilkins B. S., Johnson P. A., Williams J. H., Lee A. H., Jones D. B., Wright D. H. Microwave antigen retrieval in immunocytochemistry: a study of 80 antibodies. J Clin Pathol. 1994 May;47(5):448–452. doi: 10.1136/jcp.47.5.448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Frizzera G., Sakurai M., Notohara K., Konishi H. t(11;14) (q13;q32) in B-cell lymphomas (intermediately differentiated lymphocytic and follicular). A report of four cases. Am J Clin Pathol. 1991 May;95(5):684–691. doi: 10.1093/ajcp/95.5.684. [DOI] [PubMed] [Google Scholar]
  5. Glotzer M., Murray A. W., Kirschner M. W. Cyclin is degraded by the ubiquitin pathway. Nature. 1991 Jan 10;349(6305):132–138. doi: 10.1038/349132a0. [DOI] [PubMed] [Google Scholar]
  6. Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K., Cleary M. L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K. C. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994 Sep 1;84(5):1361–1392. [PubMed] [Google Scholar]
  7. Jaffe E. S., Bookman M. A., Longo D. L. Lymphocytic lymphoma of intermediate differentiation--mantle zone lymphoma: a distinct subtype of B-cell lymphoma. Hum Pathol. 1987 Sep;18(9):877–880. doi: 10.1016/s0046-8177(87)80262-9. [DOI] [PubMed] [Google Scholar]
  8. Kilo M. N., Dorfman D. M. The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma/chronic lymphocytic leukemia from mantle cell lymphoma. Am J Clin Pathol. 1996 Apr;105(4):451–457. doi: 10.1093/ajcp/105.4.451. [DOI] [PubMed] [Google Scholar]
  9. Langlois N. E., King G., Herriot R., Thompson W. D. An evaluation of the staining of lymphomas and normal tissues by the rabbit polyclonal antibody to protein gene product 9.5 following non-enzymatic retrieval of antigen. J Pathol. 1995 Apr;175(4):433–439. doi: 10.1002/path.1711750411. [DOI] [PubMed] [Google Scholar]
  10. Langlois N. E., King G., Herriot R., Thompson W. D. Non-enzymatic retrieval of antigen permits staining of follicle centre cells by the rabbit polyclonal antibody to protein gene product 9.5. J Pathol. 1994 Jul;173(3):249–253. doi: 10.1002/path.1711730308. [DOI] [PubMed] [Google Scholar]
  11. Lardelli P., Bookman M. A., Sundeen J., Longo D. L., Jaffe E. S. Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol. 1990 Aug;14(8):752–763. doi: 10.1097/00000478-199008000-00007. [DOI] [PubMed] [Google Scholar]
  12. Leroux D., Le Marc'Hadour F., Gressin R., Jacob M. C., Keddari E., Monteil M., Caillot P., Jalbert P., Sotto J. J. Non-Hodgkin's lymphomas with t(11;14)(q13;q32): a subset of mantle zone/intermediate lymphocytic lymphoma? Br J Haematol. 1991 Mar;77(3):346–353. doi: 10.1111/j.1365-2141.1991.tb08582.x. [DOI] [PubMed] [Google Scholar]
  13. Lukes R. J., Collins R. D. Immunologic characterization of human malignant lymphomas. Cancer. 1974 Oct;34(4 Suppl):suppl–suppl:1503. doi: 10.1002/1097-0142(197410)34:8+<1488::aid-cncr2820340822>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  14. Merz H., Malisius R., Mannweiler S., Zhou R., Hartmann W., Orscheschek K., Moubayed P., Feller A. C. ImmunoMax. A maximized immunohistochemical method for the retrieval and enhancement of hidden antigens. Lab Invest. 1995 Jul;73(1):149–156. [PubMed] [Google Scholar]
  15. Morgan J. M., Navabi H., Schmid K. W., Jasani B. Possible role of tissue-bound calcium ions in citrate-mediated high-temperature antigen retrieval. J Pathol. 1994 Dec;174(4):301–307. doi: 10.1002/path.1711740410. [DOI] [PubMed] [Google Scholar]
  16. Ott M. M., Helbing A., Ott G., Bartek J., Fischer L., Dürr A., Kreipe H., Müller-Hermelink H. K. bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma. J Pathol. 1996 Jul;179(3):238–242. doi: 10.1002/(SICI)1096-9896(199607)179:3<238::AID-PATH566>3.0.CO;2-W. [DOI] [PubMed] [Google Scholar]
  17. Perry D. A., Bast M. A., Armitage J. O., Weisenburger D. D. Diffuse intermediate lymphocytic lymphoma. A clinicopathologic study and comparison with small lymphocytic lymphoma and diffuse small cleaved cell lymphoma. Cancer. 1990 Nov 1;66(9):1995–2000. doi: 10.1002/1097-0142(19901101)66:9<1995::aid-cncr2820660925>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  18. Pittaluga S., Wlodarska I., Stul M. S., Thomas J., Verhoef G., Cassiman J. J., Van den Berghe H., de Wolf-Peeters C. Mantle cell lymphoma: a clinicopathological study of 55 cases. Histopathology. 1995 Jan;26(1):17–24. doi: 10.1111/j.1365-2559.1995.tb00615.x. [DOI] [PubMed] [Google Scholar]
  19. Strickler J. G., Medeiros L. J., Copenhaver C. M., Weiss L. M., Warnke R. A. Intermediate lymphocytic lymphoma: an immunophenotypic study with comparison to small lymphocytic lymphoma and diffuse small cleaved cell lymphoma. Hum Pathol. 1988 May;19(5):550–554. doi: 10.1016/s0046-8177(88)80203-x. [DOI] [PubMed] [Google Scholar]
  20. Swerdlow S. H., Yang W. I., Zukerberg L. R., Harris N. L., Arnold A., Williams M. E. Expression of cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of the BCL1/cyclin D1 gene. Hum Pathol. 1995 Sep;26(9):999–1004. doi: 10.1016/0046-8177(95)90090-x. [DOI] [PubMed] [Google Scholar]
  21. Treasure J., Lane A., Jones D. B., Wright D. H. CD43 expression in B cell lymphoma. J Clin Pathol. 1992 Nov;45(11):1018–1022. doi: 10.1136/jcp.45.11.1018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Vandenberghe E., De Wolf-Peeters C., van den Oord J., Wlodarska I., Delabie J., Stul M., Thomas J., Michaux J. L., Mecucci C., Cassiman J. J. Translocation (11;14): a cytogenetic anomaly associated with B-cell lymphomas of non-follicle centre cell lineage. J Pathol. 1991 Jan;163(1):13–18. doi: 10.1002/path.1711630104. [DOI] [PubMed] [Google Scholar]
  23. Weisenburger D. D., Kim H., Rappaport H. Mantle-zone lymphoma: a follicular variant of intermediate lymphocytic lymphoma. Cancer. 1982 Apr 1;49(7):1429–1438. doi: 10.1002/1097-0142(19820401)49:7<1429::aid-cncr2820490720>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  24. Weisenburger D. D., Linder J., Daley D. T., Armitage J. O. Intermediate lymphocytic lymphoma: an immunohistologic study with comparison to other lymphocytic lymphomas. Hum Pathol. 1987 Aug;18(8):781–790. doi: 10.1016/s0046-8177(87)80051-5. [DOI] [PubMed] [Google Scholar]
  25. Weisenburger D. D., Sanger W. G., Armitage J. O., Purtilo D. T. Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings. Blood. 1987 Jun;69(6):1617–1621. [PubMed] [Google Scholar]
  26. Wilkinson K. D., Lee K. M., Deshpande S., Duerksen-Hughes P., Boss J. M., Pohl J. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science. 1989 Nov 3;246(4930):670–673. doi: 10.1126/science.2530630. [DOI] [PubMed] [Google Scholar]
  27. Yang W. I., Zukerberg L. R., Motokura T., Arnold A., Harris N. L. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol. 1994 Jul;145(1):86–96. [PMC free article] [PubMed] [Google Scholar]
  28. Zukerberg L. R., Medeiros L. J., Ferry J. A., Harris N. L. Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. Am J Clin Pathol. 1993 Oct;100(4):373–385. doi: 10.1093/ajcp/100.4.373. [DOI] [PubMed] [Google Scholar]
  29. Zukerberg L. R., Yang W. I., Arnold A., Harris N. L. Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry. Am J Clin Pathol. 1995 Jun;103(6):756–760. doi: 10.1093/ajcp/103.6.756. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES